Ekso Bionics insider buys 15,540 EKSO shares

Ekso Bionics Holdings, Inc. insider Daniel Asher, a more than ten percent owner, reported an indirect open-market purchase of common stock.

Rhea-AI Filing Summary

Ekso Bionics Holdings, Inc. insider Daniel Asher, a more than ten percent owner, reported an indirect open-market purchase of common stock. On February 19, 2026, DBA Trading, LLC, an entity beneficially owned by Asher, bought 15,540 shares of common stock at an average price of $12.3013 per share. After this trade, DBA Trading, LLC held 270,432 common shares indirectly for Asher. Asher is also shown as indirectly holding 355,961 shares of convertible preferred stock through the Daniel Asher Descendants Trust, and directly holding 165,000 common shares, reflecting a significant overall stake in Ekso Bionics.

Insider Trade Summary

Net Buyer: 15,540 shares

Net Buy 3 txns

Insider ASHER DANIEL

Role 10% Owner

Bought 15,540 shs ($191K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	15,540	$12.3013	$191K
holding	Convertible Preferred Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 270,432 shares (Indirect, by DBA Trading, LLC); Convertible Preferred Stock — 355,961 contracts (Indirect, By Daniel Asher Descendants Trust); Common Stock — 165,000 shares (Direct)

Footnotes (3)

1. F1. Daniel Asher is the beneficial owner of DBA Trading, LLC and deemed to control share voting and dispositive power over the shares held by them.
2. F2. Daniel Asher is the grantor of Daniel Asher Descendants Trust and deemed to control share voting and dispositive power over the shares held by them.
3. F3. None

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did EKSO reporting person Daniel Asher disclose?

Daniel Asher reported an indirect open-market purchase of 15,540 Ekso Bionics common shares. The shares were bought on February 19, 2026, by DBA Trading, LLC at an average price of $12.3013 per share, increasing his indirect ownership stake.

At what price were the new Ekso Bionics (EKSO) shares purchased?

The newly acquired Ekso Bionics common shares were purchased at an average price of $12.3013 per share. This price reflects an open-market transaction executed on February 19, 2026, through DBA Trading, LLC, which is beneficially owned by Daniel Asher.

How many Ekso Bionics (EKSO) shares does DBA Trading, LLC hold after the transaction?

After the reported purchase, DBA Trading, LLC holds 270,432 Ekso Bionics common shares. These shares are attributed indirectly to Daniel Asher, who is the beneficial owner of DBA Trading, LLC and is deemed to control voting and dispositive power over them.

What additional Ekso Bionics (EKSO) holdings are associated with Daniel Asher?

Beyond the DBA Trading, LLC shares, Daniel Asher is shown as indirectly holding 355,961 shares of convertible preferred stock via the Daniel Asher Descendants Trust and directly holding 165,000 common shares, indicating a sizable combined ownership position in the company.

Is Daniel Asher a major shareholder of Ekso Bionics (EKSO)?

Yes. The Form 4 identifies Daniel Asher as a more than ten percent owner of Ekso Bionics. His stake includes direct common stock, indirect common stock via DBA Trading, LLC, and convertible preferred stock held through the Daniel Asher Descendants Trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/20/2026 - 04:57 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ASHER DANIEL

(Last) (First) (Middle)

1011 LAKE ST

SUITE 311

(Street)

OAK PARK IL 60301

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EKSO BIONICS HOLDINGS, INC. [ EKSO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/19/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/19/2026		P		15,540	A	$12.3013	270,432	I	by DBA Trading, LLC(1)
Common Stock								165,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Convertible Preferred Stock	$8.22							01/22/2026	(3)	Common Stock	355,961		2,926	I	By Daniel Asher Descendants Trust(2)

Explanation of Responses:

1. Daniel Asher is the beneficial owner of DBA Trading, LLC and deemed to control share voting and dispositive power over the shares held by them.

2. Daniel Asher is the grantor of Daniel Asher Descendants Trust and deemed to control share voting and dispositive power over the shares held by them.

3. None

	Daniel Asher	02/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.